Cocktail of Growth Factors Including Fibroblast Growth Factor 9 (Cellcurin) Serum in the Treatment of Androgenetic Alopecia

    May 2021
    Leonardo de Medeiros Quirino, Giovana Vilela Rocha
    Studysummary In this randomized clinical trial, the use of Cellcurin serum for 12 weeks was associated with a significant increase in hair density and terminal hair thickness in individuals with androgenetic alopecia.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →